Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07414433
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Diagnosis of hepatocellular carcinoma (HCC) based on LI-RADS CT/MRI v2018 criteria or histopathological verification
* Candidate for TACE as part of standard treatment (BCLC criteria)
* Child-Pugh score ≤ 7 at the time of TACE indication
* ECOG performance status 0 at the time of TACE indication
* Availability of at least one follow-up multiphase CT or MRI scan 4-8 weeks after TACE
Exclusion Criteria:
* Child-Pugh score ≥8 at the time of TACE indication
* Eastern Cooperative Oncology Group (ECOG) performance status \> 0 at the time of TACE indication.
* Presence of extrahepatic dissemination and/or macrovascular invasion
* Technically unfeasible TACE (e.g., inability to identify feeder artery)
* Severe uncorrectable coagulopathy or cytopenia
* Severe allergy or contraindication to iodine contrast agent or drugs used during TACE
* Pregnancy or breastfeeding
* Inability to provide signed informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07414433
Study Brief:
Protocol Section:
NCT07414433